Q1 2024 Holdings
Filed 2024-05-15 | 69 holdings | $6.8B | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Rocket Pharmaceuticals Inc(RCKT) | COM | 77313F106 | $476.5M | 17,687,772 | 7.0% |
| Immunocore Hldgs PLC(IMCR) | ADS | 45258D105 | $391.3M | 6,019,641 | 5.8% |
| Axsome Therapeutics Inc(AXSM) | COM | 05464T104 | $358.5M | 4,492,679 | 5.3% |
| Ultragenyx Pharmaceutical in(RARE) | COM | 90400D108 | $330.9M | 7,087,115 | 4.9% |
| Bruker Corp(BRKR) | COM | 116794108 | $314.1M | 3,344,095 | 4.6% |
| Argenx SE(ARGX) | SPONSORED ADR | 04016X101 | $262.7M | 667,195 | 3.9% |
| Acadia Pharmaceuticals Inc(ACAD) | COM | 004225108 | $255.7M | 13,829,315 | 3.8% |
| Natera Inc(NTRA) | COM | 632307104 | $237.2M | 2,593,323 | 3.5% |
| PTC Therapeutics Inc(PTCT) | COM | 69366J200 | $216.0M | 7,423,970 | 3.2% |
| Masimo Corp(MASI) | COM | 574795100 | $214.8M | 1,462,400 | 3.2% |
| Avidity Biosciences Inc(RNA) | COM | 05370A108 | $203.4M | 7,970,269 | 3.0% |
| Merus N V | COM | N5749R100 | $185.0M | 4,109,393 | 2.7% |
| Cytokinetics Inc(CYTK) | COM NEW | 23282W605 | $177.0M | 2,525,080 | 2.6% |
| Apogee Therapeutics Inc(APGE) | COM | 03770N101 | $164.0M | 2,467,591 | 2.4% |
| Alkermes PLC(ALKS) | SHS | G01767105 | $163.9M | 6,054,280 | 2.4% |
| Protagonist Therapeutics Inc(PTGX) | COM | 74366E102 | $153.8M | 5,315,514 | 2.3% |
| Penumbra Inc(PEN) | COM | 70975L107 | $150.8M | 675,888 | 2.2% |
| Avadel Pharmaceuticals PLC | SPONSORED ADR | 05337M104 | $148.6M | 8,798,558 | 2.2% |
| Akero Therapeutics Inc(AKRO) | COM | 00973Y108 | $137.2M | 5,431,985 | 2.0% |
| Establishment Labs Hldgs Inc(ESTA) | COM | G31249108 | $136.2M | 2,675,703 | 2.0% |
| Arvinas Inc(ARVN) | COM | 04335A105 | $136.1M | 3,297,897 | 2.0% |
| Tarsus Pharmaceuticals Inc(TARS) | COM | 87650L103 | $118.9M | 3,272,341 | 1.8% |
| Stryker Corporation(SYK) | COM | 863667101 | $114.9M | 321,000 | 1.7% |
| Madrigal Pharmaceuticals Inc(MDGL) | COM | 558868105 | $106.0M | 397,047 | 1.6% |
| Immatics N.v(IMTX) | SHS | N44445109 | $105.1M | 10,000,000 | 1.6% |
| Sage Therapeutics Inc(SG7) | COM | 78667J108 | $102.7M | 5,480,577 | 1.5% |
| Shockwave MED Inc(SWAVUSD) | COM | 82489T104 | $94.0M | 288,684 | 1.4% |
| Dyne Therapeutics Inc(DYN) | COM | 26818M108 | $87.8M | 3,091,587 | 1.3% |
| 89Bio Inc(ETNBGBP) | COM | 282559103 | $85.9M | 7,378,548 | 1.3% |
| Spyre Therapeutics Inc(SYRE) | COM NEW | 00773J202 | $84.7M | 2,232,760 | 1.3% |
| Vericel Corp(VCEL) | COM | 92346J108 | $83.6M | 1,606,397 | 1.2% |
| Cargo Therapeutics Inc(CRGX) | COM | 14179K101 | $83.4M | 3,735,619 | 1.2% |
| Radnet Inc(RDNT) | COM | 750491102 | $82.7M | 1,700,550 | 1.2% |
| Thermo Fisher Scientific Inc(TMO) | COM | 883556102 | $64.2M | 110,500 | 0.9% |
| 10X Genomics Inc(TXG) | CL A COM | 88025U109 | $58.4M | 1,554,856 | 0.9% |
| Stoke Therapeutics Inc(STOK) | COM | 86150R107 | $57.0M | 4,224,838 | 0.8% |
| Fulcrum Therapeutics Inc(FULC) | COM | 359616109 | $55.2M | 5,845,956 | 0.8% |
| Taysha Gene Therapies Inc(TSHA) | COM SHS | 877619106 | $53.4M | 18,593,185 | 0.8% |
| Insmed Inc(INSM) | COM PAR $.01 | 457669307 | $50.6M | 1,865,108 | 0.7% |
| Urogen Pharma LTD(URGN) | COM | M96088105 | $48.9M | 3,257,347 | 0.7% |
| Kyverna Therapeutics Inc(KYTX) | COM | 501976104 | $46.0M | 1,852,711 | 0.7% |
| Intuitive Surgical Inc(ISRG) | COM NEW | 46120E602 | $39.5M | 99,000 | 0.6% |
| Neurogene Inc(NGNE) | COM | 64135M105 | $39.1M | 769,122 | 0.6% |
| Janux Therapeutics Inc(JANX) | COM | 47103J105 | $37.7M | 1,000,000 | 0.6% |
| GH Research PLC(GHRS) | ORDINARY SHARES | G3855L106 | $35.5M | 3,327,129 | 0.5% |
| Orchestra Biomed Hldgs Inc(OBIO) | COM | 68572M106 | $29.6M | 5,620,640 | 0.4% |
| Dianthus Therapeutics Inc(DNTH) | COM | 252828108 | $20.0M | 666,667 | 0.3% |
| Essa Pharma Inc(EPIEUR) | COM NEW | 29668H708 | $19.5M | 2,298,662 | 0.3% |
| Lenz Therapeutics Inc(LENZ) | COM | 52635N103 | $19.3M | 863,389 | 0.3% |
| CG Oncology Inc(CGON) | COM | 156944100 | $18.2M | 413,670 | 0.3% |